首页> 外文期刊>Molecular vision >Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation
【24h】

Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation

机译:高糖处理的内皮细胞中乙酰肝素酶的上调促进内皮细胞迁移和增殖,并与Akt和细胞外信号调节的激酶磷酸化相关

获取原文
       

摘要

Purpose: The objectives of this study were to determine whether high-glucose-induced upregulation of heparanase (HPSE) expression and differential heparanase expression in human retinal vascular endothelial cells (HRECs) can alter HREC migration and proliferation. We also aimed to determine whether HREC migration and proliferation correlate with the levels of protein kinase B (Akt) and extracellular-signal-regulated kinase (ERK) phosphorylation and activation. Methods: HRECs were treated with either 5 mM glucose (Glu5) or high (30 mM) glucose (Glu30) for 48 h. Untransfected HRECs were grown in human endothelial serum-free medium (HE-SFM) in the presence of 5 mM glucose and supplemented with 30 mM mannitol for 48 h as an osmotic control (mannitol). HRECs were also infected with a heparanase small interfering RNA recombinant lentiviral vector (HPSE-LV) or a control vector (Con-LV) at a multiplicity of infection (MOI) of 60 for three days. Then the con-LV and HPSE-LV-infected cells were treated with 30 mM glucose for 48 h (Con-LV-Glu30 and HSPE-LV-Glu30, respectively). The expression levels of heparanase mRNA and protein and HREC proliferation and migration were examined using quantitative real-time polymerase chain reaction (qRT–PCR), western blot analysis, 3-(4,5-dimethylthiahiazol-2-y1)-2,5-diphenyltetrazolium bromide assay, bromodeoxyuridine histochemical staining, and the Boyden chamber assay. The expression level of paxillin was examined using immunofluorescent staining. Akt and ERK phosphorylation was evaluated using western blot analysis. Results: We successfully transfected the HPSE RNAi lentiviral vector into HRECs and demonstrated that it can suppress the expression of the heparanase gene in these cells. Western blot and qRT–PCR analyses showed that HRECs treated with a high concentration of glucose exhibited increased heparanase protein and mRNA levels, while the levels were decreased in HRECs that had been infected with HPSE-LV before treatment with high glucose (HPSE-LV-Glu30; p0.05). The observed increase or decrease in the levels of heparanase correlated with increased or decreased HREC migration and proliferation, respectively (p0.05). HREC proliferation and migration were found to correlate with Akt and ERK phosphorylation levels (p0.5). Conclusions: Our results indicate that heparanase plays a significant role in mediating retinal vascular endothelial cell proliferation and migration after the HRECs are exposed to high levels of glucose. Signaling inducing heparanase-stimulated HREC proliferation and migration appears to be related to the activation of Akt and ERK via their phosphorylation.
机译:目的:本研究的目的是确定高葡萄糖诱导的人视网膜血管内皮细胞(HREC)中乙酰肝素酶(HPSE)表达和乙酰肝素酶差异表达是否可以改变HREC迁移和增殖。我们还旨在确定HREC迁移和增殖是否与蛋白激酶B(Akt)和细胞外信号调节激酶(ERK)的磷酸化和激活水平相关。方法:HRECs用5 mM葡萄糖(Glu5)或高(30 mM)葡萄糖(Glu30)处理48小时。未转染的HRECs在人内皮无血清培养基(HE-SFM)中在5 mM葡萄糖存在下生长,并补充30 mM甘露醇作为渗透控制(甘露醇)48小时。 HREC还以60的感染复数(MOI)感染了肝素酶小干扰RNA重组慢病毒载体(HPSE-LV)或对照载体(Con-LV)。然后用30 mM葡萄糖处理con-LV和HPSE-LV感染的细胞48小时(分别为Con-LV-Glu30和HSPE-LV-Glu30)。使用定量实时聚合酶链反应(qRT-PCR),western印迹分析,3-(4,5-二甲基噻唑啉-2-y1)-2,5检测乙酰肝素酶mRNA和蛋白的表达水平以及HREC增殖和迁移。 -二苯基溴化四氮唑测定,溴脱氧尿苷组织化学染色和博登室测定。使用免疫荧光染色检查paxillin的表达水平。使用蛋白质印迹分析评估Akt和ERK磷酸化。结果:我们成功地将HPSE RNAi慢病毒载体转染到HRECs中,并证明它可以抑制乙酰肝素酶基因在这些细胞中的表达。 Western印迹和qRT-PCR分析表明,高浓度葡萄糖治疗的HRECs乙酰肝素酶和mRNA水平升高,而高糖治疗前已感染HPSE-LV的HRECs的水平降低了(HPSE-LV- Glu30; p <0.05)。观察到的乙酰肝素酶水平的增加或减少分别与HREC迁移和增殖的增加或减少相关(p <0.05)。发现HREC增殖和迁移与Akt和ERK磷酸化水平相关(p <0.5)。结论:我们的结果表明乙酰肝素酶在HRECs暴露于高水平的葡萄糖后,在介导视网膜血管内皮细胞的增殖和迁移中起重要作用。信号诱导乙酰肝素酶刺激的HREC增殖和迁移似乎与Akt和ERK的磷酸化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号